1,426 reports of this reaction
2.0% of all BIOTIN reports
#10 most reported adverse reaction
ARTHRALGIA is the #10 most commonly reported adverse reaction for BIOTIN, manufactured by Guangdong Aimu Biological Technology Co., Ltd. There are 1,426 FDA adverse event reports linking BIOTIN to ARTHRALGIA. This represents approximately 2.0% of all 70,312 adverse event reports for this drug.
Patients taking BIOTIN who experience arthralgia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ARTHRALGIA is a less commonly reported adverse event for BIOTIN, but still significant enough to appear in the safety profile.
In addition to arthralgia, the following adverse reactions have been reported for BIOTIN:
The following drugs have also been linked to arthralgia in FDA adverse event reports:
ARTHRALGIA has been reported as an adverse event in 1,426 FDA reports for BIOTIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
ARTHRALGIA accounts for approximately 2.0% of all adverse event reports for BIOTIN, making it a notable side effect.
If you experience arthralgia while taking BIOTIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.